Addressing the challenge of platinum-resistant ovarian cancer: the role of mirvetuximab soravtansine

被引：0
|
作者：
Shaukat, Ayesha [1 ]
Shakeel, Laiba [1 ]
Khan, Afsheen [1 ]
Irfan, Hamza [2 ]
Akilimali, Aymar [3 ]
机构：
[1] Dow Univ Hlth Sci, Dept Internal Med, Karachi, Pakistan
[2] Shaikh Khalifa Bin Zayed Al Nahyan Med & Dent Coll, Dept Internal Med, Lahore, Pakistan
[3] Med Res Circle, Dept Res, Goma, DEM REP CONGO
来源：
ANNALS OF MEDICINE AND SURGERY | 2025年 / 87卷 / 01期
关键词：
EXPRESSION; CISPLATIN; WOMEN;
D O I：
10.1097/MS9.0000000000002759
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 7
页数：7
相关论文
共 50 条
  • [1] Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
    Moore, K. N.
    Angelergues, A.
    Konecny, G. E.
    Garcia, Y.
    Banerjee, S.
    Lorusso, D.
    Lee, J. -Y.
    Moroney, J. W.
    Colombo, N.
    Roszak, A.
    Tromp, J.
    Myers, T.
    Lee, J. -W.
    Beiner, M.
    Cosgrove, C. M.
    Cibula, D.
    Martin, L. P.
    Sabatier, R.
    Buscema, J.
    Estevez-Garcia, P.
    Coffman, L.
    Nicum, S.
    Duska, L. R.
    Pignata, S.
    Galvez, F.
    Wang, Y.
    Method, M.
    Berkenblit, A.
    Roufai, D. Bello
    Van Gorp, T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (23) : 2162 - 2174
  • [2] Mirvetuximab soravtansine: A breakthrough in targeted therapy for platinum-resistant ovarian cancer
    Kokori, Emmanuel
    Olatunji, Gbolahan
    Komolafe, Rosemary
    Abraham, Israel Charles
    Ukoaka, Bonaventure
    Samuel, Owolabi
    Ayodeji, Akinmeji
    Ogunbowale, Ibukunoluwa
    Ezenwoba, Chidiogo
    Aderinto, Nicholas
    MEDICINE, 2024, 103 (20) : E38132
  • [3] FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer
    Moore, Kathleen N.
    Vergote, Ignace
    Oaknin, Ana
    Colombo, Nicoletta
    Banerjee, Susana
    Oza, Amit
    Pautier, Patricia
    Malek, Karim
    Birrer, Michael J.
    FUTURE ONCOLOGY, 2018, 14 (17) : 1669 - 1678
  • [4] Mirvetuximab soravtansine in folate receptor alpha-positive, platinum-resistant ovarian cancers: a profile of its use
    Fung, Simon
    Syed, Yahiya Y.
    DRUGS & THERAPY PERSPECTIVES, 2024, 40 (02) : 53 - 60
  • [5] Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
    Moore, K. N.
    Oza, A. M.
    Colombo, N.
    Oaknin, A.
    Scambia, G.
    Lorusso, D.
    Konecny, G. E.
    Banerjee, S.
    Murphy, C. G.
    Tanyi, J. L.
    Hirte, H.
    Konner, J. A.
    Lim, P. C.
    Prasad-Hayes, M.
    Monk, B. J.
    Pautier, P.
    Wang, J.
    Berkenblit, A.
    Vergote, I
    Birrer, M. J.
    ANNALS OF ONCOLOGY, 2021, 32 (06) : 757 - 765
  • [6] Immunotherapy for platinum-resistant ovarian cancer
    Bogani, Giorgio
    Lopez, Salvatore
    Mantiero, Mara
    Ducceschi, Monika
    Bosio, Sara
    Ruisi, Simona
    Sarpietro, Giuseppe
    Guerrisi, Rocco
    Brusadelli, Claudia
    Dell'Acqua, Andrea
    Di Donato, Violante
    Raspagliesi, Francesco
    GYNECOLOGIC ONCOLOGY, 2020, 158 (02) : 484 - 488
  • [7] The role of surgery in platinum-resistant ovarian cancer: A call to the scientific community
    Petrillo, Marco
    Sozzi, Giulio
    Dessole, Margherita
    Capobianco, Giampiero
    Dessole, Salvatore
    Madonia, Massimo
    Cherchi, Pier Luigi
    Paoletti, Anna Maria
    Scambia, Giovanni
    Chiantera, Vito
    SEMINARS IN CANCER BIOLOGY, 2021, 77 : 194 - 202
  • [8] The Application of Biomaterials in the Treatment of Platinum-Resistant Ovarian Cancer
    Levy, Arkene
    Leynes, Carolina
    Baig, Mirza
    Chew, Sue Anne
    CHEMMEDCHEM, 2019, 14 (21) : 1810 - 1827
  • [9] Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer
    Yan, Jinbowen
    Xu, Fangzhi
    Zhou, Dan
    Zhang, Shuo
    Zhang, Bo
    Meng, Qingwei
    Lv, Qiubo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [10] Patient-reported outcomes from the MIRASOLtrial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial
    Van Gorp, Toon
    Moore, Kathleen N.
    Konecny, Gottfried E.
    Leary, Alexandra
    Garcia-Garcia, Yolanda
    Banerjee, Susana
    Lorusso, Domenica
    Lee, Jung-Yun
    Moroney, John W.
    Caruso, Giuseppe
    Klasa-Mazurkiewicz, Dagmara
    Tromp, Jacqueline
    Martin, Lainie P.
    Breuer, Shani
    Iii, Charles A. Leath
    Cibula, David
    Weroha, S. John
    Estevez-Garcia, Purificacion
    O'Malley, David M.
    Miller, Rowan E.
    Coffman, Lan
    Scandurra, Giuseppa
    Berton, Dominique
    Li, Lingling
    Zagadailov, Erin
    Diver, Elisabeth J.
    Tredan, Olivier
    Hilpert, Felix
    LANCET ONCOLOGY, 2025, 26 (04) : 503 - 515
12345